II. Physiology

  1. Maturation
    1. Forms in Bone Marrow from Myeloblasts as with other Granulocytes (Basophils, Neutrophils, Monocytes)
    2. Matures in Bone Marrow over 8 days
    3. Moves to peripheral blood where it spends 8-12 hours
    4. Moves to target tissue where it spends 1-2 weeks
  2. Function: Response to Allergy and Parasitic Infection
    1. Responds to Mast Cell, Basophil chemotactic factors
    2. Type 1 Hypersensitivity Response - Late Phase (hours after exposure)
    3. Phagocyte (engulfs extracellular pathogens)
    4. Parasite (e.g. Helminth) response
    5. Antigen Presenting Cell
  3. Eosinophil granule contents (Proteins)
    1. Antiparasitic Agents with tissue toxicity effect
      1. Major Basic Protein (MBP)
      2. Eosinophil Cationic Protein (ECP)
      3. Eosinophil Peroxidase (EPO)
    2. Neurotoxins
      1. Eosinophil-Derived Neurotoxin (EDN)
      2. Eosinophil Peroxidase (EPO) - also listed above
    3. Markers of Eosinophil activity in Asthma
      1. Major Basic Protein (MBP) - also listed above
      2. Eosinophil Cationic Protein (ECP) - also listed above
    4. Other Proteins
      1. Charcot-Leyden Crystals
      2. Lysophosphatase
      3. Cytokines
  4. Surface Receptors
    1. IgE Receptors
      1. IgE-Antigen complex binding results in Eosinophil activation and degranulation
    2. IgG Receptors
    3. Complement Receptors

III. Labs: Morphology on Blood Smear

  1. Granulocyte stains brightly with Eosin Stain (due to Major Basic Protein or MBP)
  2. Bilobed nucleus
  3. Diameter: 12-17 microns

IV. Interpretation: Normal

  1. Range: 1-4% of peripheral blood cells

V. Types: Eosinophilia

  1. Familial Eosinophilia (Familial Hypereosinophilic Syndrome)
    1. Rare autosomal condition (most Hypereosinophilic Syndromes are not inherited)
  2. Acquired
    1. Primary Eosinophilia
      1. Idiopathic
        1. Hypereosinophilic Syndrome (>1500 Eosinophils/uL x6 months without known cause)
      2. Clonal Eosinophilia
        1. Acute Myeloid Leukemia and other malignancies (see below)
    2. Secondary Eosinophilia
      1. See below

VI. Causes: Increased (Eosinophilia)

VII. Evaluation: Eosinophilia (Eosinophils >500/mm3)

  1. See Leukocytosis
  2. History and potential causes
    1. Travel history
    2. New medications
  3. Diagnostics (consider)
    1. Dermatitis biopsy (if present)
    2. Consider allergy and immunology Consultation or testing
    3. Consider Parasite testing (e.g. stool Ova and Parasites)

VIII. References

  1. Mahmoudi (2014) Immunology Made Ridiculously Simple, MedMaster, Miami, FL
  2. Saiki in Friedman (1991) Medical Diagnosis, p. 227
  3. Abramson (2000) Am Fam Physician 62(9):2053-60 [PubMed]
  4. Riley (2015) Am Fam Physician 92(11):1004-11 [PubMed]

Images: Related links to external sites (from Bing)

OSZAR »